Strides Arcolab gets US FDA’s nod for Adenoscan Injection Generic

25 Mar 2014 Evaluate

Strides Arcolab has received US Food and Drug Administration (US FDA) approval for Adenoscan Injection Generic. Astellas Pharma’s heart drug Adenoscan sales stood at $65 million per year. Teva pharma’s Adenoscan exclusivity has ended on March 23, 2014.

Adenoscan is used for diagnostic purposes as an adjunct to thallium-201 myocardial perfusion scintigraphy. Adenocard and generic adenosine products are labeled for use in paroxysmal supraventricular tachycardia.

Strides Arcolab is a global pharmaceutical company headquartered in Bangalore, India that develops and manufactures wide range of IP-lead niche pharmaceutical products with an emphasis on sterile injectables.

Strides Pharma Scien Share Price

796.30 2.70 (0.34%)
28-Jan-2026 12:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1618.95
Dr. Reddys Lab 1220.75
Cipla 1315.20
Zydus Lifesciences 892.30
Lupin 2123.65
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×